Question 1

What are the potential benefits of participating in this trial compared to my current treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP) clinical trial (NCT06338995). Contact the study team or your healthcare provider for specific answers.

Question 2

How will I be monitored during the study, and what tests will I need to undergo?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP) clinical trial (NCT06338995). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the possible side effects of lebrikizumab?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP) clinical trial (NCT06338995). Contact the study team or your healthcare provider for specific answers.

Question 4

How long will the study last, and how often will I need to visit the clinic?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP) clinical trial (NCT06338995). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any other treatment options available for my condition that I should consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP) clinical trial (NCT06338995). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience worsening symptoms during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP) clinical trial (NCT06338995). Contact the study team or your healthcare provider for specific answers.

What this study is about